A randomized, open-label, multicenter trial of topical tacrolimus for the treatment of pruritis in patients with atopic dermatitis

Annals of Dermatology

Volumn 24, Issue 2, 2012, Pages 144-150

  Takeuchi, Satoshi ^a   Saeki, Hidehisa ^a,c   Tokunaga, Shoji ^a,c   Sugaya, Makoto ^a,b   Ohmatsu, Hanako ^a,b   Tsunemi, Yuichiro ^a,b   Torii, Hideshi ^a,d   Nakamura, Koichiro ^a,e   Kawakami, Tamihiro ^a,f   Soma, Yoshinao ^a,f   Gyotoku, Eiichi ^a,g   Hide, Michihiro ^a,g   Sasaki, Rikako ^a,h   Ohya, Yukihiro ^a,h   Kido, Makiko ^a   Furue, Masutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYUSHU UNIVERSITY HOSPITAL   (Japan)

^d Social Insurance Chuo General Hospital   (Japan)

^e SAITAMA MEDICAL UNIVERSITY   (Japan)

^f ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g HIROSHIMA UNIVERSITY   (Japan)

^h NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Atopic dermatitis; Maintenance therapy; Pruritis; Randomized trial; Tacrolimus

Indexed keywords

EID: 84860643529     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2012.24.2.144     Document Type: Article

References (21)

1. Takeuchi M, Ueda H. Increase of adult atopic dermatitis (AD) in recent Japan. Environ Dermatol 2000;7:133-136.
2. Yamamoto S. Prevalence and exacerbation factors of atopic dermatitis. Skin Allergy Frontier 2003;1:85-90.
3. Ikoma A, Steinhoff M, Ständer S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat Rev Neurosci 2006;7:535-547. (Pubitemid 43995431)
4. Rossi R, Johansson O. Cutaneous innervation and the role of neuronal peptides in cutaneous inflammation: a minireview. Eur J Dermatol 1998;8:299-306. (Pubitemid 28341832)
5. Ständer S, Steinhoff M, Schmelz M, Weisshaar E, Metze D, Luger T. Neurophysiology of pruritus: cutaneous elicitation of itch. Arch Dermatol 2003;139:1463-1470. (Pubitemid 37441284)
6. Furue M, Terao H, Rikihisa W, Urabe K, Kinukawa N, Nose Y, et al. Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. Br J Dermatol 2003;148:128-133. (Pubitemid 36114873)
7. Wahlgren CF. Itch and atopic dermatitis: clinical and experimental studies. Acta Derm Venereol Suppl (Stockh) 1991;165:1-53.
8. Boguniewicz M, Fiedler VC, Raimer S, Lawrence ID, Leung DY, Hanifin JM. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. J Allergy Clin Immunol 1998;102:637-644.
9. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993;186:23-31.
10. Furue M, Terao H, Moroi Y, Koga T, Kubota Y, Nakayama J, et al. Dosage and adverse effects of topical tacrolimus and steroids in daily management of atopic dermatitis. J Dermatol 2004;31:277-283. (Pubitemid 38590770)
11. Fleischer AB Jr, Ling M, Eichenfield L, Satoi Y, Jaracz E, Rico MJ, et al. Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections. J Am Acad Dermatol 2002;47:562-570.
12. Rivard J, Lim HW. Ultraviolet phototherapy for pruritus. Dermatol Ther 2005;18:344-354. (Pubitemid 41801855)
13. Chuang TY, Heinrich LA, Schultz MD, Reizner GT, Kumm RC, Cripps DJ. PUVA and skin cancer. A historical cohort study on 492 patients. J Am Acad Dermatol 1992;26:173-177.
14. Hon KL, Lam MC, Leung TF, Chow CM, Wong E, Leung AK. Assessing itch in children with atopic dermatitis treated with tacrolimus: objective versus subjective assessment. Adv Ther 2007;24:23-28. (Pubitemid 46700862)
15. Reitamo S, Rustin M, Ruzicka T, Cambazard F, Kalimo K, Friedmann PS, et al; European Tacrolimus Ointment Study Group. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 2002;109:547-555. (Pubitemid 34234209)
16. Japanese FK-506 Ointment Study Group. Phase III study of FK-506 (Tacrolimus) ointment in patients with atopic dermatitis-Comparison study with 0.12% betamethasone valerate ointment for trunk and extremities lesions-. Nishinihon J Dermatol 1997;59:870-879. (article in Japanese)
17. Inagaki N, Shiraishi N, Igeta K, Itoh T, Chikumoto T, Nagao M, et al. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone. Eur J Pharmacol 2006;546:189-196. (Pubitemid 44331846)
18. Inagaki N, Shiraishi N, Igeta K, Nagao M, Kim JF, Chikumoto T, et al. Depletion of substance P, a mechanism for inhibition of mouse scratching behavior by tacrolimus. Eur J Pharmacol 2010;626:283-289.
19. Inoue T, Katoh N, Kishimoto S. Prolonged topical application of tacrolimus inhibits immediate hypersensitivity reactions by reducing degranulation of mast cells. Acta Derm Venereol 2006;86:13-16. (Pubitemid 46939781)
20. Kido M, Takeuchi S, Esaki H, Hayashida S, Furue M. Scratching behavior does not necessarily correlate with epidermal nerve fiber sprouting or inflammatory cell infiltration. J Dermatol Sci 2010;58:130-135.
21. Takeuchi S, Yasukawa F, Furue M, Katz SI. Collared mice: a model to assess the effects of scratching. J Dermatol Sci 2010;57:44-50.